3Babu Y S, Chand P, Bantia S, et al. BCX-1812 (RWJ-270201 ): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design [ J ]. J Med Chem, 2000, 43 (19) : 3482-3486.
4Bantia S, Arnold C S, Parker C D, et al. Anti-influenza virus activity of peramivir in mice with single intramuscular injection[ J ]. Antiv Res, 2006, 69 (1) : 39 -45.
5Smee D F, Huffman J H, Morrison A C, et al. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities [J]. Antimicrob Agents Chemother, 2001, 45 (3) : 743-748.
6Mineno T, Miller M J. Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents [ J ]. J Org Chem,2003, 68(17) : 6591 +6596.
7Hanessian S, Wang J, Montgomery D, et al. Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm [J]. Bioor g Med Chem Lett , 2002 ,12 ( 23 ) :3425-3429.
8Stoll V, Stewart K D, Maring C J, et al. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series [J]. Biochemistry,2003,3(7):718-727.
9Yi X, Guo Z R, Chu F M. Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors [J]. Bioorg Med Chem,2003,11(6428) :1465-1474.
10Von Itzstein M, Wu W Y, Kok G B, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication [J]. Nature, 1993,363 : 418-423.
